These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6014006)

  • 1. [Resorption, blood levels and elimination of meso-inositol-14C-hexanicotinate following oral administration to cats].
    Brattgård SO; Brattsand R; Harthon JG
    Arzneimittelforschung; 1966 Feb; 16(2):145-6. PubMed ID: 6014006
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.
    Lan SJ; Chando TJ; Weliky I; Schreiber EC
    J Pharmacol Exp Ther; 1973 Aug; 186(2):323-30. PubMed ID: 4719785
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzymatic hydrolysis of pentaerythritoltetranicotinate and meso-inositolhexanicotinate in blood and tissues.
    Harthon L; Brattsand R
    Arzneimittelforschung; 1979; 29(12):1859-62. PubMed ID: 546424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].
    Paltauf F; Pristautz H; el Eisch IA
    Acta Med Austriaca; 1977; 4(3):120-4. PubMed ID: 930544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some aspects of sorbinicate pharmacokinetics.
    Subissi A; Biagi M; Murmann W
    Arzneimittelforschung; 1980; 30(8):1278-84. PubMed ID: 7192142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of inositol hexanicotinate in rat plasma by high performance liquid chromatography with UV detection.
    Liang D; Ma J; Wei B; Poon IO; Bell EC; Bates TR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):172-6. PubMed ID: 18207467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption in rats, dogs, pigs, and humans of nicotinic acid after oral administration of phosphatidyl inositol pentanicotinate hydrochloride (PIN).
    Hertle H; Kiese M; Renner G
    Arzneimittelforschung; 1979; 29(1):114-6. PubMed ID: 582105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the uptake and effect of hexanicotinic acid-esters of meso-inosit in the body].
    Brandt H; Fromm H
    Dtsch Med J; 1966 Mar; 17(6):176-8. PubMed ID: 5973781
    [No Abstract]   [Full Text] [Related]  

  • 10. On the absorption, distribution and excretion of sorbinicate in the rat and the monkey.
    Giachetti C; Mondino A; Silvestri S; Zanolo G; Bramanti G; Criscuoli M; Subissi A
    Arzneimittelforschung; 1982; 32(11):1433-6. PubMed ID: 6891249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Animal experiment on the absorption, distribution and elimination of C 14 - and H 3 -labelled guaiacol-glyceryl-ether].
    Rossberg F; Luther D
    Acta Biol Med Ger; 1971; 26(2):331-9. PubMed ID: 5142865
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of meso-inositol hexanicotinate on arteriosclerosis].
    Kimura N; Nishimoto S; Mori I; Mizuguchi N; Yoshinaga M
    Nihon Rinsho; 1966 Mar; 24(3):576-82. PubMed ID: 6007313
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ocular changes experimentally induced in guinea pigs treated with an association of kallikrein and meso-inositol hexanicotinate].
    Ronchieri M
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(1):544-54. PubMed ID: 5761261
    [No Abstract]   [Full Text] [Related]  

  • 14. [APROPOS OF THE GASTROINTESTINAL ABSORPTION OF INOSITOL HEXANICOTINATE].
    CHITI W
    Farmaco Prat; 1964 Aug; 19():378-84. PubMed ID: 14177540
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the fibrinolytic effect of the combination of kallikrein with meso-inositol hexanicotinate].
    Zedda S
    Clin Ter; 1967 Sep; 42(6):509-24. PubMed ID: 5617888
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotinic acid-6-14C metabolism in man.
    Lee KW; Abelson DM; Kwon YO
    Am J Clin Nutr; 1968 Mar; 21(3):223-5. PubMed ID: 5642898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
    Blasi A; Licciardello M
    Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON THE ELIMINATION OF UNABSORBED HEXANICOTINIC ACID ESTERS OF MESO-INOSITOL IN THE FECES].
    HARTHON JG; LINDQVIST JT
    Arzneimittelforschung; 1964 Oct; 14():1170-1. PubMed ID: 14343489
    [No Abstract]   [Full Text] [Related]  

  • 20. [The interrelationship between iron and nicotinic acid metabolism in the organism of animals].
    Gaĭdenko AI
    Vopr Pitan; 1966; 25(5):37-41. PubMed ID: 6001348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.